Felipe C Geyer Selected Research

Felipe C Geyer Research Topics

Disease

39	Neoplasms (Cancer) 01/2021 - 04/2009
26	Breast Neoplasms (Breast Cancer) 03/2022 - 04/2009
8	Carcinoma (Carcinomatosis) 01/2020 - 04/2009
4	Melanoma (Melanoma, Malignant) 12/2019 - 07/2010
4	Ductal Carcinoma 01/2012 - 11/2009
3	Neoplasm Metastasis (Metastasis) 08/2017 - 02/2011
3	Lobular Carcinoma 02/2017 - 02/2011
2	Pathologic Complete Response 03/2022 - 01/2018
2	Papillary Carcinoma 01/2020 - 08/2018
2	Triple Negative Breast Neoplasms 10/2017 - 01/2016
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017 - 04/2016
1	Intraductal Papilloma 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 08/2018
1	Papillary Thyroid Cancer 08/2018
1	Adenomyoepithelioma 01/2018
1	Endometrioid Carcinoma 09/2017
1	Acinar Cell Carcinoma 01/2017
1	Metaplasia 01/2017
1	Disease Progression 01/2016
1	Confusion (Bewilderment) 07/2013
1	Genetic Translocation (Chromosomal Translocation) 01/2012
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2010
1	Fibroma (Fibromatosis) 11/2010
1	Endometrial Neoplasms (Endometrial Cancer) 10/2010
1	Adenocarcinoma 10/2010
1	Adenosquamous Carcinoma 07/2010
1	Neuroendocrine Carcinoma 11/2009

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 01/2019 - 04/2009
9	Phenobarbital (Luminal)FDA Link 01/2018 - 04/2009
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2010
5	Cadherins (E-Cadherin)IBA 01/2021 - 11/2010
4	AntibodiesIBA 01/2020 - 11/2010
3	Monoclonal AntibodiesIBA 01/2020 - 12/2010
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2016 - 11/2010
3	CateninsIBA 07/2013 - 11/2010
3	Biomarkers (Surrogate Marker)IBA 02/2011 - 10/2009
3	AnthracyclinesIBA 01/2011 - 10/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 01/2018 - 01/2018
2	Codon (Codons)IBA 01/2018 - 01/2018
2	Lapatinib (GW572016)FDA Link 01/2018 - 09/2017
2	ParaffinIBA 03/2017 - 01/2012
2	Formaldehyde (Formol)FDA Link 03/2017 - 01/2012
2	Keratin-14 (Keratin 14)IBA 10/2013 - 02/2012
2	CortactinIBA 12/2010 - 11/2010
2	Messenger RNA (mRNA)IBA 06/2010 - 04/2009
2	OligonucleotidesIBA 01/2010 - 11/2009
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2019
1	MucinsIBA 01/2019
1	bis(pyridinio)dichlorocuprate(II)IBA 08/2018
1	neratinibIBA 09/2017
1	AfatinibIBA 09/2017
1	MTOR InhibitorsIBA 07/2017
1	Complex MixturesIBA 03/2017
1	SynaptophysinIBA 02/2017
1	Transcription Factors (Transcription Factor)IBA 02/2017
1	Chromogranin AIBA 02/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	ClaudinsIBA 01/2017
1	Cyclin-Dependent Kinase 2IBA 03/2012
1	Phosphotransferases (Kinase)IBA 03/2012
1	Mucin-1 (CA 15-3 Antigen)IBA 02/2012
1	AntigensIBA 02/2012
1	ChromograninsIBA 02/2012
1	NucleotidesIBA 02/2012
1	Progesterone FDA LinkGeneric 02/2012
1	Androgen Receptors (Androgen Receptor)IBA 02/2012
1	Nonsense Codon (Nonsense Mutation)IBA 02/2012
1	Keratin-7 (Cytokeratin 7)IBA 02/2012
1	Caveolin 1IBA 01/2012
1	Pyridinolcarbamate (P23)IBA 01/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2012
1	CarcinogensIBA 05/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	Cyclin D1IBA 11/2010
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 10/2010
1	KU0058948IBA 10/2010
1	TensinsIBA 10/2010
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2010
1	MagnesiumIBA 10/2010
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2010
1	Indicators and Reagents (Reagents)IBA 08/2010
1	Cre recombinaseIBA 07/2010
1	Monomeric GTP-Binding ProteinsIBA 07/2010
1	Keratins (Keratin)IBA 07/2010
1	Hormones (Hormone)IBA 12/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2009

Therapy/Procedure

9	Therapeutics 01/2020 - 10/2009
8	Drug Therapy (Chemotherapy) 01/2020 - 10/2010
2	Neoadjuvant Therapy 03/2022 - 01/2020
2	Precision Medicine 12/2019 - 10/2017
1	Radiotherapy 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Lasers (Laser) 07/2019